comparemela.com

Latest Breaking News On - Tessa romero - Page 2 : comparemela.com

This biotech stock targeting genetic diseases could nearly double, predicts JPMorgan

This under-the-radar biotech is targeting genetic heart disorders with gene therapies could boost its stock price by 82%, according to JPMorgan.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript

Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.

vimarsana © 2020. All Rights Reserved.